These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 34499615)

  • 1. Knockdown of PSMC2 contributes to suppression of cholangiocarcinoma development by regulating CDK1.
    Duan X; Yang J; Jiang B; Duan W; Wei R; Zhang H; Mao X
    Aging (Albany NY); 2021 Sep; 13(17):21325-21344. PubMed ID: 34499615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PSMC2 knockdown inhibits the progression of oral squamous cell carcinoma by promoting apoptosis via PI3K/Akt pathway.
    Wang Z; Xiong H; Zuo Y; Hu S; Zhu C; Min A
    Cell Cycle; 2022 Mar; 21(5):477-488. PubMed ID: 34979867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PSMC2/CCND1 axis promotes development of ovarian cancer through regulating cell growth, apoptosis and migration.
    Zhu D; Huang J; Liu N; Li W; Yan L
    Cell Death Dis; 2021 Jul; 12(8):730. PubMed ID: 34294689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PSMC2 is up-regulated in osteosarcoma and regulates osteosarcoma cell proliferation, apoptosis and migration.
    Song M; Wang Y; Zhang Z; Wang S
    Oncotarget; 2017 Jan; 8(1):933-953. PubMed ID: 27888613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of PSMC2 promotes the tumorigenesis and development of human breast cancer via regulating plasminogen activator urokinase (PLAU).
    Wang Y; Zhu M; Li J; Xiong Y; Wang J; Jing H; Gu Y
    Cell Death Dis; 2021 Jul; 12(7):690. PubMed ID: 34244472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silencing of Proteasome 26S Subunit ATPase 2 Regulates Colorectal Cancer Cell Proliferation, Apoptosis, and Migration.
    He J; Xing J; Yang X; Zhang C; Zhang Y; Wang H; Xu X; Wang H; Cao Y; Xu H; Zhang C; Wang C; Yu E
    Chemotherapy; 2019; 64(3):146-154. PubMed ID: 31715603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GSG2 knockdown suppresses cholangiocarcinoma progression by regulating cell proliferation, apoptosis and migration.
    Zhou J; Nie W; Yuan J; Zhang Z; Mi L; Wang C; Huang R
    Oncol Rep; 2021 Jun; 45(6):. PubMed ID: 33846801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-494-dependent WDHDI inhibition suppresses epithelial-mesenchymal transition, tumor growth and metastasis in cholangiocarcinoma.
    Liu B; Hu Y; Qin L; Peng XB; Huang YX
    Dig Liver Dis; 2019 Mar; 51(3):397-411. PubMed ID: 30314946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the PI3K/AKT/mTOR pathway offer a promising therapeutic strategy for cholangiocarcinoma patients with high doublecortin-like kinase 1 expression.
    Liang Z; Ge Y; Li J; Bai Y; Xiao Z; Yan R; An G; Zhang D
    J Cancer Res Clin Oncol; 2024 Jul; 150(7):342. PubMed ID: 38980538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockdown of tripartite motif 59 (TRIM59) inhibits proliferation in cholangiocarcinoma via the PI3K/AKT/mTOR signalling pathway.
    Shen H; Zhang J; Zhang Y; Feng Q; Wang H; Li G; Jiang W; Li X
    Gene; 2019 May; 698():50-60. PubMed ID: 30822475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gankyrin promotes tumor growth and metastasis through activation of IL-6/STAT3 signaling in human cholangiocarcinoma.
    Zheng T; Hong X; Wang J; Pei T; Liang Y; Yin D; Song R; Song X; Lu Z; Qi S; Liu J; Sun B; Xie C; Pan S; Li Y; Luo X; Li S; Fang X; Bhatta N; Jiang H; Liu L
    Hepatology; 2014 Mar; 59(3):935-46. PubMed ID: 24037855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of chondroitin polymerizing factor (CHPF) as tumor promotor in cholangiocarcinoma through regulating cell proliferation, cell apoptosis and cell migration.
    Duan X; Yang J; Jiang B; Duan W; Wei R; Zhang H; Mao X
    Cell Cycle; 2021; 20(5-6):591-602. PubMed ID: 33651657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RPL35A promotes the progression of cholangiocarcinoma by mediating HSPA8 ubiquitination.
    Zhang C; Wang Y; Wu G; Sun N; Bai H; Li X; Han S; Zhou H; Qi R; Zhang J
    Biol Direct; 2024 Feb; 19(1):16. PubMed ID: 38395908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IRF4-induced upregulation of lncRNA SOX2-OT promotes cell proliferation and metastasis in cholangiocarcinoma by regulating SOX2 and PI3K/AKT signaling.
    Wei CX; Wong H; Xu F; Liu Z; Ran L; Jiang RD
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8169-8178. PubMed ID: 30556855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PSMC2 knockdown exerts an anti-tumor role in nasopharyngeal carcinoma through regulating AKT signaling pathway.
    Su J; Hu S; Ding S; Feng K
    Cell Cycle; 2023 Nov; 22(21-22):2381-2391. PubMed ID: 38123344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. S100A8 facilitates cholangiocarcinoma metastasis via upregulation of VEGF through TLR4/NF‑κB pathway activation.
    Pan S; Hu Y; Hu M; Xu Y; Chen M; Du C; Cui J; Zheng P; Lai J; Zhang Y; Bai J; Jiang P; Zhu J; He Y; Wang J
    Int J Oncol; 2020 Jan; 56(1):101-112. PubMed ID: 31746424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The deubiquitinase USP5 promotes cholangiocarcinoma progression by stabilizing YBX1.
    Ning F; Du L; Li J; Wu T; Zhou J; Chen Z; Hu X; Zhang Y; Luan X; Xin H; Yuan C; Zhang X
    Life Sci; 2024 Jul; 348():122674. PubMed ID: 38692507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knockdown of cullin 3 inhibits progressive phenotypes and increases chemosensitivity in cholangiocarcinoma cells.
    Pratummanee K; Kerdkumthong K; Roytrakul S; Tantimetta P; Runsaeng P; Saeheng S; Obchoei S
    Mol Med Rep; 2024 Nov; 30(5):. PubMed ID: 39239747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PIN1 promotes the metastasis of cholangiocarcinoma cells by RACK1-mediated phosphorylation of ANXA2.
    Wang Y; Liu Y; Chen H; Xu Z; Jiang W; Xu X; Shan J; Chang J; Zhou T; Wang J; Chenyan A; Fan S; Tao Z; Shao K; Li X; Chen X; Ji G; Wu X
    Cell Oncol (Dordr); 2024 Aug; 47(4):1233-1252. PubMed ID: 38386231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PSMC2 is overexpressed in glioma and promotes proliferation and anti-apoptosis of glioma cells.
    Zheng X; Wang Y; Wang D; Wan J; Qin X; Mu Z; Hu N
    World J Surg Oncol; 2022 Mar; 20(1):84. PubMed ID: 35287689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.